You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 15, 2025

Details for Patent: 11,957,832


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,957,832
Title:Breath actuated inhaler
Abstract:A breath actuated metered dose inhaler may comprise a canister fire system configured to fire a medicament containing canister in response to patient inhalation. The canister fire system may comprise a pneumatic force holding unit and having a rest configuration in which a metering valve of the canister is in a refill configuration; a prepared configuration in which a canister actuation force is retained by the pneumatic force holding unit and the canister fire system is actuatable by patient inhalation induced airflow; and a fire configuration in which the metering valve is in a dose delivery position. When in the prepared configuration, the force retained by the pneumatic force holding unit may be reduced by less than about 6% over a period of 5 minutes, preferably less than about 3% over a period of 5 minutes.
Inventor(s):Declan Walsh, Paul Prendergast, Daniel Buck, Trevor Kent, Niall Thompson
Assignee:Norton Waterford Ltd
Application Number:US17/062,185
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a Patent: A Detailed Analysis Using US Patent 11,957,832 as an Example

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial. This analysis will use the hypothetical example of US Patent 11,957,832, though the actual patent details are not provided, to illustrate key concepts and best practices in patent drafting and the patent landscape.

The Importance of Claim Scope

The scope of a patent claim defines the boundaries of what is protected by the patent. It is a delicate balance between broad protection and specificity to avoid invalidation.

  • Broad vs. Specific Claims: A common misconception is that broader claims are always better. However, broader claims are more difficult to get granted and easier to invalidate. The right claim scope depends on factors such as the actual invention, prior art, client budget, and the technical field[3].

Drafting Patent Claims

Effective patent claims must be anchored to the embodiments disclosed in the specification but can go beyond the specific details.

  • Written Description Requirement: Claims must meet the written description requirement, meaning they must be supported by the specification. Overly broad claims can fail this requirement and be invalidated[3].

  • Abstract Idea Exception: Claims that are too broad may fall under the abstract idea exception, as seen in the Supreme Court's Alice decision. This exception prevents patents from preempting abstract ideas by requiring specific means or methods that improve the relevant technology[3].

Example: Breath Actuated Inhaler

Consider a breath actuated inhaler, such as the one described in US10792447B2. This patent includes specific claims about the configuration of the canister fire system, the holding unit, and the response to patient inhalation.

  • Specific Configurations: The claims detail the valve, canister, and holding unit configurations, ensuring that the patent is specific enough to avoid broad invalidation grounds. For instance, the patent specifies the use of polymers, sealing methods, and the response effects to patient inhalation[1].

Patent Landscape and Challenges

The patent landscape is dynamic, with various mechanisms for challenging patent validity.

Inter Partes Review (IPR) and Post-Grant Review (PGR)

  • Administrative Challenges: The Leahy-Smith America Invents Act (AIA) created the Patent Trial and Appeal Board (PTAB) to hear administrative challenges such as IPR and PGR. These processes allow parties to challenge the validity of issued patents in a faster and less expensive manner compared to federal court litigation[5].

  • Burden of Proof: IPR and PGR require a lower burden of proof (preponderance of the evidence) compared to federal court (clear and convincing evidence), making it more feasible for challengers to invalidate patents[5].

Case Studies and Best Practices

Hyatt v. Hirshfeld

  • Claim Management: The case of Hyatt v. Hirshfeld highlights the importance of managing claim scope. Gilbert P. Hyatt filed numerous applications with extensive claim sets, which were eventually narrowed down by the PTO to ensure distinct subject matter. This case underscores the need for focused and distinct claims to avoid rejection and invalidation[2].

Teva Pharmaceutical Industries

  • Optimized Designs: Teva's patent for an inhaler with multiple outlets and a deagglomerator shows how specific configurations and features can enhance the effectiveness of the invention. The patent details cross-sectional areas of the outlets, air inlet shapes, and delivery passageways, demonstrating how precise claims can protect innovative designs[4].

Key Considerations for Patent Applicants

  • Prior Art: The level of prior art in the technical field can significantly impact the claim scope. In fields with extensive prior art, broader claims are more likely to be rejected or invalidated[3].

  • Client Budget: The cost of getting a patent granted on broader claims is higher due to the increased complexity and potential for challenges. Applicants must balance the scope of claims with budget constraints[3].

  • Technical Field: The technical field influences the appropriate claim scope. For example, in the pharmaceutical industry, specific claims about drug delivery mechanisms and configurations are crucial for protecting innovations[4].

Highlight: Importance of Specificity

"A patent with overly broad claims runs the risks of being invalidated. For an overly broad claim, two invalidation grounds are frequently used. One is the abstract idea exception and the other is failure to meet the written description requirement."[3]

Key Takeaways

  • Balanced Claim Scope: The claim scope must be balanced between broad protection and specificity to avoid invalidation.
  • Written Description: Claims must be supported by the specification to meet the written description requirement.
  • Administrative Challenges: Mechanisms like IPR and PGR provide faster and less expensive ways to challenge patent validity.
  • Prior Art and Budget: Consider the level of prior art and client budget when determining the claim scope.
  • Technical Field: The technical field influences the appropriate level of specificity in claims.

FAQs

  1. What is the importance of claim scope in a patent application?

    • The claim scope defines the boundaries of what is protected by the patent. It must be balanced between broad protection and specificity to avoid invalidation.
  2. Why are broader claims more difficult to get granted?

    • Broader claims are more difficult to get granted because they are easier to challenge and invalidate, especially under the abstract idea exception and failure to meet the written description requirement.
  3. What is the role of the Patent Trial and Appeal Board (PTAB)?

    • PTAB is a tribunal within the USPTO that hears administrative challenges such as IPR and PGR, providing a faster and less expensive way to challenge the validity of issued patents.
  4. How does prior art affect the claim scope?

    • In fields with extensive prior art, broader claims are more likely to be rejected or invalidated. Therefore, the claim scope must be tailored to avoid prior art.
  5. What are the key considerations for patent applicants when drafting claims?

    • Key considerations include the level of prior art, client budget, and the technical field. Claims must be specific enough to avoid invalidation but broad enough to provide meaningful protection.

Sources

  1. US10792447B2 - Breath actuated inhaler - Google Patents
  2. Hyatt v. Hirshfeld - Court of Appeals for the Federal Circuit
  3. The Importance of Getting the Claim Scope Right in a US Patent Application - Rimon Law
  4. Teva Pharmaceutical Industries Ltd Patent for Inhaler with Multiple Outlets and Deagglomerator - Pharmaceutical Technology
  5. The Patent Trial and Appeal Board and Inter Partes Review - Congressional Research Service

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 11,957,832

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Norton Waterford QVAR REDIHALER beclomethasone dipropionate AEROSOL, METERED;INHALATION 207921-001 Aug 3, 2017 RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Norton Waterford QVAR REDIHALER beclomethasone dipropionate AEROSOL, METERED;INHALATION 207921-002 Aug 3, 2017 RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.